(RBLX) Roblox - Overview
Stock: Platform, Client, Studio, Cloud
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 69.0% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | -9.41 |
| Character TTM | |
|---|---|
| Beta | 1.260 |
| Beta Downside | 1.407 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.21% |
| CAGR/Max DD | 0.51 |
Description: RBLX Roblox January 27, 2026
Roblox Corporation (NYSE:RBLX) runs a user-generated, immersive 3D platform that connects creators and players worldwide through three core products: the Roblox Client for end-user experiences, Roblox Studio-a free development suite for building and publishing games, and Roblox Cloud, which supplies the backend services and infrastructure that keep the ecosystem running. The company was founded in 2004 and is headquartered in San Mateo, California.
As of the most recent quarterly filing (Q2 FY 2025, ended September 30 2024), Roblox reported 73.5 million monthly active users (MAU), a 1.4 % increase YoY, and a 12 % rise in average revenue per paying user (ARPPU) to $33.5, driving quarterly revenue to $620 million-up 9 % from the prior quarter. The firm’s cash conversion cycle remains negative, with cash generated from operations of $140 million, reflecting strong monetization of its creator economy.
Key macro-level drivers for Roblox include sustained growth in youth digital engagement (U.S. Gen-Z internet usage rose 3 % YoY in 2023), expanding advertiser interest in immersive ad formats, and the broader “metaverse” trend that is prompting higher capital allocation to interactive home entertainment. Conversely, discretionary spending pressure from tighter consumer budgets and potential regulatory scrutiny of in-app purchases for minors represent downside risks.
For a deeper, data-rich assessment of how these dynamics translate into valuation metrics, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -1.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 6.48 > 1.0 |
| NWC/Revenue: -4.67% < 20% (prev 1.80%; Δ -6.47% < -1%) |
| CFO/TA 0.19 > 3% & CFO 1.80b > Net Income -1.07b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (701.9m) vs 12m ago 6.20% < -2% |
| Gross Margin: 23.75% > 18% (prev 0.78%; Δ 2298 % > 0.5%) |
| Asset Turnover: 58.46% > 50% (prev 50.20%; Δ 8.26% > 0%) |
| Interest Coverage Ratio: -39.70 > 6 (EBITDA TTM -1.01b / Interest Expense TTM 31.0m) |
Altman Z'' -3.45
| A: -0.02 (Total Current Assets 4.90b - Total Current Liabilities 5.13b) / Total Assets 9.56b |
| B: -0.53 (Retained Earnings -5.06b / Total Assets 9.56b) |
| C: -0.15 (EBIT TTM -1.23b / Avg Total Assets 8.37b) |
| D: -0.55 (Book Value of Equity -5.04b / Total Liabilities 9.18b) |
| Altman-Z'' Score: -3.45 = D |
Beneish M -0.92
| DSRI: 1.05 (Receivables 900.6m/634.5m, Revenue 4.89b/3.60b) |
| GMI: 3.27 (GM 23.75% / 77.76%) |
| AQI: 1.11 (AQ_t 0.33 / AQ_t-1 0.30) |
| SGI: 1.36 (Revenue 4.89b / 3.60b) |
| TATA: -0.30 (NI -1.07b - CFO 1.80b) / TA 9.56b) |
| Beneish M-Score: -0.92 (Cap -4..+1) = D |
What is the price of RBLX shares?
Over the past week, the price has changed by +8.85%, over one month by +0.25%, over three months by -30.29% and over the past year by +12.91%.
Is RBLX a buy, sell or hold?
- StrongBuy: 15
- Buy: 5
- Hold: 8
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the RBLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.6 | 57.4% |
| Analysts Target Price | 115.6 | 57.4% |
| ValueRay Target Price | 76.5 | 4.1% |
RBLX Fundamental Data Overview February 08, 2026
P/S = 9.5331
P/B = 114.3902
P/EG = 8.1775
Revenue TTM = 4.89b USD
EBIT TTM = -1.23b USD
EBITDA TTM = -1.01b USD
Long Term Debt = 992.7m USD (from longTermDebt, two quarters ago)
Short Term Debt = 153.7m USD (from shortTermDebt, two quarters ago)
Debt = 1.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 431.1m USD (from netDebt column, last quarter)
Enterprise Value = 45.20b USD (46.62b + Debt 1.64b - CCE 3.06b)
Interest Coverage Ratio = -39.70 (Ebit TTM -1.23b / Interest Expense TTM 31.0m)
EV/FCF = 30.64x (Enterprise Value 45.20b / FCF TTM 1.48b)
FCF Yield = 3.26% (FCF TTM 1.48b / Enterprise Value 45.20b)
FCF Margin = 30.17% (FCF TTM 1.48b / Revenue TTM 4.89b)
Net Margin = -21.78% (Net Income TTM -1.07b / Revenue TTM 4.89b)
Gross Margin = 23.75% ((Revenue TTM 4.89b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = -110.0% (prev 78.20%)
Tobins Q-Ratio = 4.73 (Enterprise Value 45.20b / Total Assets 9.56b)
Interest Expense / Debt = 0.63% (Interest Expense 10.4m / Debt 1.64b)
Taxrate = 21.0% (US default 21%)
NOPAT = -973.6m (EBIT -1.23b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.96 (Total Current Assets 4.90b / Total Current Liabilities 5.13b)
Debt / Equity = 4.15 (Debt 1.64b / totalStockholderEquity, last quarter 394.5m)
Debt / EBITDA = -0.43 (negative EBITDA) (Net Debt 431.1m / EBITDA -1.01b)
Debt / FCF = 0.29 (Net Debt 431.1m / FCF TTM 1.48b)
Total Stockholder Equity = 366.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -12.73% (Net Income -1.07b / Total Assets 9.56b)
RoE = -290.6% (Net Income TTM -1.07b / Total Stockholder Equity 366.5m)
RoCE = -90.66% (EBIT -1.23b / Capital Employed (Equity 366.5m + L.T.Debt 992.7m))
RoIC = -71.36% (negative operating profit) (NOPAT -973.6m / Invested Capital 1.36b)
WACC = 10.22% (E(46.62b)/V(48.26b) * Re(10.56%) + D(1.64b)/V(48.26b) * Rd(0.63%) * (1-Tc(0.21)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.19%
[DCF Debug] Terminal Value 70.49% ; FCFF base≈1.14b ; Y1≈1.15b ; Y5≈1.23b
Fair Price DCF = 22.31 (EV 15.04b - Net Debt 431.1m = Equity 14.61b / Shares 654.9m; r=10.22% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: 4.07 | EPS CAGR: -22.55% | SUE: 0.18 | # QB: 0
Revenue Correlation: 98.28 | Revenue CAGR: 29.47% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.43 | Chg30d=+0.020 | Revisions Net=+0 | Analysts=9
EPS current Year (2026-12-31): EPS=-1.67 | Chg30d=+0.039 | Revisions Net=+1 | Growth EPS=-8.1% | Growth Revenue=+24.3%
EPS next Year (2027-12-31): EPS=-1.17 | Chg30d=+0.043 | Revisions Net=+0 | Growth EPS=+29.5% | Growth Revenue=+18.5%